| PLGA-based nanoparticles: an overview of biomedical applications F Danhier, E Ansorena, JM Silva, R Coco, A Le Breton, V Préat Journal of controlled release 161 (2), 505-522, 2012 | 3561 | 2012 |
| To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery F Danhier, O Feron, V Préat Journal of controlled release 148 (2), 135-146, 2010 | 2884 | 2010 |
| Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach A des Rieux, V Fievez, M Garinot, YJ Schneider, V Préat Journal of controlled release 116 (1), 1-27, 2006 | 1574 | 2006 |
| RGD-based strategies to target alpha (v) beta (3) integrin in cancer therapy and diagnosis F Danhier, A Le Breton, V Préat Molecular pharmaceutics 9 (11), 2961-2973, 2012 | 981 | 2012 |
| Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation F Danhier, N Lecouturier, B Vroman, C Jérôme, J Marchand-Brynaert, ... Journal of controlled release 133 (1), 11-17, 2009 | 705 | 2009 |
| Skin electroporation for transdermal and topical delivery AR Denet, R Vanbever, V Préat Advanced drug delivery reviews 56 (5), 659-674, 2004 | 649 | 2004 |
| Nanostructured lipid carriers: Promising drug delivery systems for future clinics A Beloqui, MÁ Solinís, A Rodríguez-Gascón, AJ Almeida, V Préat Nanomedicine: Nanotechnology, biology and medicine 12 (1), 143-161, 2016 | 598 | 2016 |
| Chitosan and chitosan derivatives in drug delivery and tissue engineering R Riva, H Ragelle, A des Rieux, N Duhem, C Jérôme, V Préat Chitosan for biomaterials II, 19-44, 2011 | 461 | 2011 |
| Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel F Danhier, B Vroman, N Lecouturier, N Crokart, V Pourcelle, H Freichels, ... Journal of Controlled Release 140 (2), 166-173, 2009 | 425 | 2009 |
| PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination M Garinot, V Fiévez, V Pourcelle, F Stoffelbach, A des Rieux, L Plapied, ... Journal of controlled release 120 (3), 195-204, 2007 | 410 | 2007 |
| Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance C Bosquillon, C Lombry, V Preat, R Vanbever Journal of controlled release 70 (3), 329-339, 2001 | 370 | 2001 |
| Fate of polymeric nanocarriers for oral drug delivery L Plapied, N Duhem, A des Rieux, V Préat Current opinion in colloid & interface science 16 (3), 228-237, 2011 | 368 | 2011 |
| Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium A des Rieux, EGE Ragnarsson, E Gullberg, V Préat, YJ Schneider, ... European Journal of Pharmaceutical Sciences 25 (4-5), 455-465, 2005 | 356 | 2005 |
| An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells A des Rieux, V Fievez, I Théate, J Mast, V Préat, YJ Schneider european journal of pharmaceutical sciences 30 (5), 380-391, 2007 | 352 | 2007 |
| Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures H Ragelle, F Danhier, V Préat, R Langer, DG Anderson Expert opinion on drug delivery 14 (7), 851-864, 2017 | 333 | 2017 |
| Combined effect of PLGA and curcumin on wound healing activity KK Chereddy, R Coco, PB Memvanga, B Ucakar, A des Rieux, ... Journal of controlled release 171 (2), 208-215, 2013 | 302 | 2013 |
| In Vivo Methods for the Assessment of Topical Drug Bioavailability C Herkenne, I Alberti, A Naik, YN Kalia, FX Mathy, V Préat, RH Guy Pharmaceutical research 25, 87-103, 2008 | 294 | 2008 |
| Stability study of nanoparticles of poly (ɛ-caprolactone), poly (d, l-lactide) and poly (d, l-lactide-co-glycolide) D Lemoine, C Francois, F Kedzierewicz, V Preat, M Hoffman, P Maincent Biomaterials 17 (22), 2191-2197, 1996 | 281 | 1996 |
| Cancer DNA vaccines: current preclinical and clinical developments and future perspectives A Lopes, G Vandermeulen, V Préat Journal of Experimental & Clinical Cancer Research 38, 1-24, 2019 | 278 | 2019 |
| Immune system targeting by biodegradable nanoparticles for cancer vaccines JM Silva, M Videira, R Gaspar, V Préat, HF Florindo Journal of controlled release 168 (2), 179-199, 2013 | 272 | 2013 |
